Institutional Ownership
Vistagen Therapeutics Inc
CUSIP 92840H400COMVTGNQ1 2026
Institutional Holders
53
13F filers
Shares Held
12.93M
Aggregate institutional
Institutional Value
$6.72M
Q1 2026
Net New Holders
+0
13 new · 13 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions13
Increased14
Decreased9
Sold out13
Institutional Holders
53 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbimed Advisors LLC | 3.06M | $1.75M | 0 | Held |
| 2 | Tcg Crossover Management, LLC | 2.68M | $1.53M | 0 | Held |
| 3 | Adar1 Capital Management, LLC | 751.1K | $429.3K | +127.6K | Added |
| 4 | Ikarian Capital, LLC | 519.1K | $296.7K | 0 | Held |
| 5 | Two Sigma Investments, LP | 469.6K | $268.4K | +274.0K | Added |
| 6 | Geode Capital Management, LLC | 453.4K | $259.2K | +100.6K | Added |
| 7 | Blackrock, Inc. | 448.5K | $256.3K | +25.7K | Added |
| 8 | Millennium Management LLC | 430.4K | $246.0K | +233.4K | Added |
| 9 | Luminus Management LLC | 396.1K | $226.3K | +46.1K | Added |
| 10 | Renaissance Technologies LLC | 291.3K | $166.5K | +130.5K | Added |
43 more institutional holders on Premium
See every fund holding Vistagen Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders